Keros Therapeutics shares owned by Schonfeld Strategic Advisors
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Schonfeld Strategic Advisors
from 13F filings
Historical chart of Schonfeld Strategic Advisors investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Keros Therapeutics by Schonfeld Strategic Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $12M | 199k | 58.07 |
2024-06-30 | $1.6M | 34k | 45.70 |
2024-03-31 | $4.0M | 60k | 66.20 |
2023-12-31 | $3.8M | 95k | 39.76 |
2023-09-30 | $2.5M | 78k | 31.88 |
2023-06-30 | $3.5M | 87k | 40.18 |
2023-03-31 | $2.4M | 57k | 42.70 |
2022-12-31 | $1.9M | 40k | 48.02 |
2022-03-31 | $984k | 18k | 54.37 |
2021-12-31 | $939k | 16k | 58.53 |
2021-03-31 | $1.0M | 17k | 61.54 |
More positions owned by Schonfeld Strategic Advisors
View all positions for Schonfeld Strategic Advisors